Discontinued — last reported Q3 '23
Applied Materials Interest Paid decreased by 4.4% to $65.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 25.0%, from $52.00M to $65.00M. Over 4 years (FY 2021 to FY 2025), Interest Paid shows an upward trend with a 3.9% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase in interest paid relative to debt levels may signal rising borrowing costs or higher leverage, while a decrease may indicate debt reduction or refinancing at lower rates.
The total cash outflow for interest payments on debt obligations, typically disclosed as a supplemental item in the cash...
Essential for comparing the cost of capital and debt burden across peers in the pharmaceutical industry.
cf_interest_paid| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $68.00M | $34.00M | $68.00M | $34.00M | $68.00M | $35.00M | $68.00M | $34.00M | $68.00M | $35.00M | $68.00M | $34.00M | $68.00M | $35.00M | $68.00M | $52.00M | $68.00M | $51.00M | $68.00M | $65.00M |
| QoQ Change | — | -50.0% | +100.0% | -50.0% | +100.0% | -48.5% | +94.3% | -50.0% | +100.0% | -48.5% | +94.3% | -50.0% | +100.0% | -48.5% | +94.3% | -23.5% | +30.8% | -25.0% | +33.3% | -4.4% |
| YoY Change | — | — | — | — | +0.0% | +2.9% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +52.9% | +0.0% | +45.7% | +0.0% | +25.0% |
We use cookies for analytics. See our Privacy and Cookie Policy.